The journal is expected to provide an open academic platform for exchange of knowledge, ideas, and latest researches among scholars worldwide to make a truly top-tier journal in this field.
The journal publishes articles related to the full spectrum of medical and surgical interest in vascular diseases, including acute respiratory distress syndrome (ARDS), aneurysm, atherosclerosis, hypertension, stroke, thrombosis, ischemic heart disease, peripheral vascular or pulmonary vascular diseases, as well as genetic diseases such as Arterial Tortuosity Syndrome, Cystic Fibrosis, Ehlers-Danlos, Marfan, Parkes-Weber, or Klippel-Trénaunay Syndrome. This journal focuses on the latest clinical and basic research on the prevention, treatment, prognosis, and mechanisms of diseases of the blood vessels including original articles, case reports, commentaries, and expert reviews in molecular biology, physiology, and pathophysiology of the blood vessels.
All articles published by VP
are made freely and permanently accessible online immediately from the date of publication. Articles are published under a Creative Commons Attribution 4.0 International License
(CC BY). The CC BY allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license users are free to share (copy, distribute and transmit) and remix (adapt) the contribution for any purposes, even commercially, provided that the users appropriately acknowledge the original authors and the source.
Authors retain the copyright of their works as well as the rights to make certain uses of the works.
For more information about the editorial team, please refer to Editorial Board
Journal Information and Statistics
Launch date: March 31, 2017
Publication model: Open access
ISSN 2574-1209 (Online)
Digital archive: Portico
Frequency: Continuously published
Average time from submission to first decision: 42 days
Average time from acceptance to online publication: 12 days
All articles published in VP are included in:
Chaoxing "Domain" Publishing Platform
Please visit Contact Us
for details about different queries.